Breaking News - The Fly

Open Search

KA

Kineta

$

()

Kineta presents data from Phase 1/2 VISTA-101 clinical trial at AACR

KA

4/8/2024 - 16:08pm

Kineta clears additional cohorts in Phase 1/2 VISTA-101 trial

KA , MRK

3/12/2024 - 08:27am

Kineta to reduce workforce by 64% in corporate restructuring

KA

2/29/2024 - 08:35am

Kineta to present new preclinical data on KVA12123

KA

2/22/2024 - 08:32am

Kineta provides update on ongoing Phase 1/2 VISTA-101 trial of KVA12123

KA

1/17/2024 - 08:35am

Kineta publishes preclinical data on KVA12123

KA

12/13/2023 - 08:32am

Kineta announces new data from VISTA-101 trial of KVA12123

KA

11/6/2023 - 08:44am

Kineta files to sell 890K shares of common stock for holders

KA

11/3/2023 - 16:28pm

Kineta announces first patient dosed in Phase 1/2 VISTA-101 trial of KVA12123

KA , MRK

10/17/2023 - 08:32am

Kineta presents new preclinical data on anti-CD27 agonist

KA

10/4/2023 - 08:35am

Kineta announces $3M registered direct offering priced at $3.37 per share

KA

10/4/2023 - 08:04am

Kineta announces KVA12123 data from Phase 1/2 VISTA-101 trial

KA

10/3/2023 - 08:38am

Kineta enters research agreement with Fred Hutchinson Cancer Center

KA

9/18/2023 - 09:34am

Kineta reports Q2 EPS 4c vs. ($1.23) last year

KA

8/11/2023 - 16:03pm

Kineta to Receive $5M milestone payment from Merck

KA , MRK

6/29/2023 - 06:32am